Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Muto

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitorsHidenobu Murafuji, Tsuyoshi Muto, Megumi Goto, et al.
European Journal of Pharmacology|November 11, 2008
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitisMaki Terakawa, Yusuke Fujieda, Yoshiaki Tomimori, et al.
Bioorganic & Medicinal Chemistry|June 24, 2015
Orally active ghrelin receptor inverse agonists and their actions on a rat obesity modelBitoku Takahashi, Hideaki Funami, Takehiko Iwaki, et al.
The Journal of Investigative Dermatology|January 27, 2007
Oral administration of chymase inhibitor improves dermatitis in NC/Nga miceNaohiro Watanabe, Yoshiaki Tomimori, Maki Terakawa, et al.
Bioorganic & Medicinal Chemistry|February 13, 2020
Discovery and structure-activity relationships of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiationKatsushi Katayama, Yoshikazu Arai, Kenji Murata, et al.
Biochemical Pharmacology|September 18, 2002
Role of mast cell chymase in allergen-induced biphasic skin reactionYoshiaki Tomimori, Nobuo Tsuruoka, Harukazu Fukami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
Chymase participates in chronic dermatitis by inducing eosinophil infiltrationYoshiaki Tomimori, Tsuyoshi Muto, Harukazu Fukami, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell DiseaseKatsushi Katayama, Ken Ishii, Hideki Terashima, et al.
Biochemical and Biophysical Research Communications|February 1, 2002
Mast cell chymase regulates dermal mast cell number in miceYoshiaki Tomimori, Tsuyoshi Muto, Harukazu Fukami, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2018
Synthesis and evaluation of N-(4-benzylphenyl)piperazines as VGF inducersTetsuya Toba, Ryosuke Suzuki, Junko Futamura-Takahashi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitorsHidenobu Murafuji, Tsuyoshi Muto, Megumi Goto, et al.
European Journal of Pharmacology|November 11, 2008
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitisMaki Terakawa, Yusuke Fujieda, Yoshiaki Tomimori, et al.
Bioorganic & Medicinal Chemistry|June 24, 2015
Orally active ghrelin receptor inverse agonists and their actions on a rat obesity modelBitoku Takahashi, Hideaki Funami, Takehiko Iwaki, et al.
The Journal of Investigative Dermatology|January 27, 2007
Oral administration of chymase inhibitor improves dermatitis in NC/Nga miceNaohiro Watanabe, Yoshiaki Tomimori, Maki Terakawa, et al.
Bioorganic & Medicinal Chemistry|February 13, 2020
Discovery and structure-activity relationships of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiationKatsushi Katayama, Yoshikazu Arai, Kenji Murata, et al.
Biochemical Pharmacology|September 18, 2002
Role of mast cell chymase in allergen-induced biphasic skin reactionYoshiaki Tomimori, Nobuo Tsuruoka, Harukazu Fukami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
Chymase participates in chronic dermatitis by inducing eosinophil infiltrationYoshiaki Tomimori, Tsuyoshi Muto, Harukazu Fukami, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell DiseaseKatsushi Katayama, Ken Ishii, Hideki Terashima, et al.
Biochemical and Biophysical Research Communications|February 1, 2002
Mast cell chymase regulates dermal mast cell number in miceYoshiaki Tomimori, Tsuyoshi Muto, Harukazu Fukami, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2018
Synthesis and evaluation of N-(4-benzylphenyl)piperazines as VGF inducersTetsuya Toba, Ryosuke Suzuki, Junko Futamura-Takahashi, et al.
Pageof 4